United Kingdom

Aventis Pharma ltd t/a Sanofi

Reference: GB-PPON-PMBG-8218-QDPT

Open in El Vínculo

Awards

€3,372,342,713

Total awarded

Recent awards

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £665,389,588
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £166,347,397
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
1 June 2026 · £813,863,584
NHS National Branded Interim - 1 June 2026
10 April 2026 · £529,090,780
NHS National Generic Pharmaceuticals - Wave 15c
13 January 2026 · £403,702,000
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
28 November 2025 · £321,349,256
NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS National Branded Interim - 1 June 2026

Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.